E Bernard

725 total citations
53 papers, 556 citations indexed

About

E Bernard is a scholar working on Pharmacology, Epidemiology and Surgery. According to data from OpenAlex, E Bernard has authored 53 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 15 papers in Epidemiology and 14 papers in Surgery. Recurrent topics in E Bernard's work include Antibiotics Pharmacokinetics and Efficacy (16 papers), Orthopedic Infections and Treatments (10 papers) and Antimicrobial Resistance in Staphylococcus (9 papers). E Bernard is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (16 papers), Orthopedic Infections and Treatments (10 papers) and Antimicrobial Resistance in Staphylococcus (9 papers). E Bernard collaborates with scholars based in France, Vietnam and Germany. E Bernard's co-authors include P. Dellamonica, R. Garraffo, P Lapalus, Éric Cua, H Drugeon, C. Pulcini, V. Mondain, J. Durant, Pierre‐Marie Roger and H. Carsenti-Etesse and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Drugs.

In The Last Decade

E Bernard

51 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Bernard France 13 204 204 180 172 95 53 556
A. M. Clarke Canada 14 166 0.8× 205 1.0× 166 0.9× 50 0.3× 138 1.5× 30 566
W R Bowie Canada 14 142 0.7× 252 1.2× 66 0.4× 80 0.5× 81 0.9× 23 576
C. W. Norden United States 12 127 0.6× 223 1.1× 148 0.8× 314 1.8× 101 1.1× 14 690
H. Bradford Hawley United States 11 136 0.7× 178 0.9× 172 1.0× 47 0.3× 102 1.1× 26 538
W. John Spicer Australia 13 112 0.5× 107 0.5× 145 0.8× 92 0.5× 70 0.7× 34 469
Massimo Crapis Italy 12 157 0.8× 318 1.6× 284 1.6× 85 0.5× 115 1.2× 35 590
Yang Ree Kim South Korea 14 72 0.4× 225 1.1× 150 0.8× 123 0.7× 174 1.8× 29 537
N. Galanakis Greece 10 122 0.6× 170 0.8× 62 0.3× 80 0.5× 111 1.2× 16 367
H.A. Verbrugh Netherlands 10 95 0.5× 183 0.9× 165 0.9× 56 0.3× 52 0.5× 20 458
Cunha Ba United States 12 98 0.5× 174 0.9× 98 0.5× 133 0.8× 59 0.6× 51 474

Countries citing papers authored by E Bernard

Since Specialization
Citations

This map shows the geographic impact of E Bernard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Bernard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Bernard more than expected).

Fields of papers citing papers by E Bernard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Bernard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Bernard. The network helps show where E Bernard may publish in the future.

Co-authorship network of co-authors of E Bernard

This figure shows the co-authorship network connecting the top 25 collaborators of E Bernard. A scholar is included among the top collaborators of E Bernard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Bernard. E Bernard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Courjon, Johan, Élisa Demonchy, Éric Cua, E Bernard, & Pierre‐Marie Roger. (2017). Efficacy and safety of clindamycin-based treatment for bone and joint infections: a cohort study. European Journal of Clinical Microbiology & Infectious Diseases. 36(12). 2513–2518. 11 indexed citations
2.
Kumar, Gaurav, Michel Ticchioni, Christophe Trojani, et al.. (2013). T cells from chronic bone infection show reduced proliferation and a high proportion of CD28− CD4 T cells. Clinical & Experimental Immunology. 176(1). 49–57. 22 indexed citations
3.
Dellamonica, P., et al.. (2001). How to organise antibiotic prescription. International Journal of Antimicrobial Agents. 18(3). 299–303. 5 indexed citations
4.
Carsenti-Etesse, H., Robert Farinotti, J. Durant, et al.. (1998). Pharmacokinetic parameters and killing rates in serum of volunteers receiving amoxicillin, cefadroxil or cefixime alone or associated with niflumic acid or paracetamol. European Journal of Drug Metabolism and Pharmacokinetics. 23(3). 357–366. 12 indexed citations
5.
Pradier, Christian, Brigitte Dunais, R. Largillier, et al.. (1997). Nasopharyngeal carriage of Streptococcus pneumoniae in children's day-care centers; 10-month follow-up study in Nice, France. Clinical Microbiology and Infection. 3(6). 705–708. 12 indexed citations
6.
Bernard, E, Michel Carlès, C. Laffont, J. Durant, & P. Dellamonica. (1994). Guillain-Barré syndrome associated with acute Q fever. European Journal of Clinical Microbiology & Infectious Diseases. 13(8). 658–659. 13 indexed citations
7.
Bernard, E, et al.. (1994). Pharmacokinetics and suction blister fluid penetration of a semisynthetic injectable streptogramin RP 59500 (RP 57669/ RP 54476). European Journal of Clinical Microbiology & Infectious Diseases. 13(9). 768–771. 9 indexed citations
8.
Chichmanian, R M, et al.. (1993). [Thrombopenia due to pefloxacin (Peflacine): dose-dependent toxicity?].. PubMed. 47(5). 419–21. 5 indexed citations
9.
Carsenti-Etesse, H., J. Durant, E Bernard, et al.. (1992). Effect of subinhibitory concentrations of cefamandole and cefuroxime on adherence ofStaphylococcus aureus andStaphylococcus epidermidis to polystyrene culture plates. European Journal of Clinical Microbiology & Infectious Diseases. 11(8). 732–737. 5 indexed citations
10.
Mondain, V., et al.. (1990). Les osteites a staphylocoques coagulase-negatifs. Médecine et Maladies Infectieuses. 20. 98–102. 2 indexed citations
11.
Dellamonica, P., et al.. (1989). Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis. European Journal of Clinical Microbiology & Infectious Diseases. 8(12). 1024–1030. 35 indexed citations
12.
Garraffo, R., et al.. (1988). Cinétique de la diffusion de la péfloxacine dans le tissu osseux humain après perfusion unique de 800 mg. Evaluation de la technique d'extraction par le chloroforme.. Pathologie Biologie. 36. 2 indexed citations
13.
Garraffo, R., Alexis M. Barbarin, E Bernard, et al.. (1988). [Kinetics of pefloxacin diffusion in human bone tissue following a single infusion of 800 mg. Evaluation of an extraction technic using chloroform].. PubMed. 36(5 Pt 2). 715–8. 4 indexed citations
14.
Garraffo, R., P. Dellamonica, Jean Fournier, et al.. (1987). Effet de la rifampicine sur la pharmacocinétique de la doxycycline.. Pathologie Biologie. 35. 4 indexed citations
15.
Bernard, E, et al.. (1987). [Bone infections: treatment by ofloxacin. Apropos of 10 cases].. PubMed. 35(5). 644–7. 2 indexed citations
16.
Garraffo, R., et al.. (1987). Study on the bioequivalence of ciprofloxacin 500 mg orally versus 200 mg i.v.. PubMed. 6(2 Suppl). 298–300. 1 indexed citations
17.
Dellamonica, P., et al.. (1982). Facteurs discriminants du risque infectieux en chirurgie digestive réglée. Essai à propos de trois cent huit cas.. Annales de Chirurgie. 36. 1 indexed citations
18.
Dellamonica, P., et al.. (1982). Brucellose aiguë avec thrombopénie et anticorps cytotoxiques.. ˜La œNouvelle presse médicale. 11(32). 2418–2418. 1 indexed citations
19.
Bernard, E, et al.. (1968). &'* CAS DE POLYCHIMIOTHérapie prolongée dans des cancers avancés (surtout broncho-pulmonaires). Modalités et résultats.. 24(1). 1 indexed citations
20.
Bernard, E, et al.. (1954). Note préliminaire sur la vaccination intensive par voie buccale chez le nourrisson et l'enfant du premier age; le B. C. G. test d'accompagnement.. 18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. M. Clarke Breakdown of academic impact, for papers by W R Bowie Breakdown of academic impact, for papers by C. W. Norden Breakdown of academic impact, for papers by H. Bradford Hawley Breakdown of academic impact, for papers by W. John Spicer Breakdown of academic impact, for papers by Massimo Crapis Breakdown of academic impact, for papers by Yang Ree Kim Breakdown of academic impact, for papers by N. Galanakis Breakdown of academic impact, for papers by H.A. Verbrugh Breakdown of academic impact, for papers by Cunha Ba
Rankless by CCL
2026